Vireo Growth (VREOF) Total Debt (2020 - 2026)
Vireo Growth's (VREOF) quarterly Total Debt came in at $198.6 million in Q1 2026, up 217.23% year-on-year from $62.6 million in Q1 2025, and up 38.01% quarter-over-quarter from $143.9 million in Q4 2025.
Vireo Growth (VREOF) Total Debt (2020 - 2026) Analysis & Trends
Vireo Growth has disclosed Total Debt across 7 years of filings, most recently posting $198.6 million for Q1 2026.
- Total Debt for Q1 2026 came in at $198.6 million, up 217.23% year-over-year; the trailing twelve-month figure through Mar 2026 was $198.6 million (up 217.23% YoY), and the FY2025 annual result was $143.9 million, up 127.69% from the prior year.
- Total Debt came in at $198.6 million for Q1 2026 at Vireo Growth, up from $143.9 million in the prior quarter.
- In the past five years, Total Debt ranged from a high of $198.6 million in Q1 2026 to a low of $31.2 million in Q1 2022.
- The 5-year median for Total Debt is $60.9 million (2024), against an average of $81.0 million.
- Across the five-year window, Total Debt plunged 47.53% in 2024 and surged 217.23% in 2026, its largest moves.
- Vireo Growth's Total Debt stood at $58.0 million in 2022, then soared by 107.55% to $120.4 million in 2023, then tumbled by 47.53% to $63.2 million in 2024, then soared by 127.69% to $143.9 million in 2025, then surged by 38.01% to $198.6 million in 2026.
- The last three Total Debt figures came in at $198.6 million (Q1 2026), $143.9 million (Q4 2025), and $131.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 16.63 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 9.05 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 3.53 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 3.99 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 1.51 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 570.41 Mn |
| 10 | Vireo Growth | - | - | 59.30 Mn | 198.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 198.60 Mn |
| Dec 31, 2025 | 143.90 Mn |
| Sep 30, 2025 | 131.83 Mn |
| Jun 30, 2025 | 108.70 Mn |
| Mar 31, 2025 | 62.60 Mn |
| Dec 31, 2024 | 63.20 Mn |
| Sep 30, 2024 | 57.98 Mn |
| Jun 30, 2024 | 62.62 Mn |
| Mar 31, 2024 | 60.90 Mn |
| Dec 31, 2023 | 120.44 Mn |
| Sep 30, 2023 | 59.49 Mn |
| Jun 30, 2023 | 57.77 Mn |
| Mar 31, 2023 | 58.21 Mn |
| Dec 31, 2022 | 58.03 Mn |
| Sep 30, 2022 | 55.63 Mn |
| Jun 30, 2022 | 45.85 Mn |
| Mar 31, 2022 | 31.21 Mn |
| Dec 31, 2021 | 27.33 Mn |
| Sep 30, 2021 | 20.52 Mn |
| Jun 30, 2021 | 19.64 Mn |